Group 1 - The company, Chengdu Berry Genomics Technology Co., Ltd., has agreed to provide a joint liability guarantee for its wholly-owned subsidiary, Beijing Berry Genomics Biotechnology Co., Ltd., which applied for a comprehensive credit line of 30 million yuan from the Bank of China [1] - The board of directors approved the guarantee without needing to submit it to the shareholders' meeting, as per relevant regulations [1] - The total amount of external guarantees provided by the company and its subsidiaries is 317 million yuan, accounting for 18.87% of the latest audited net assets [3][4] Group 2 - The subsidiary, Beijing Berry, has total assets of approximately 2.15 billion yuan and total liabilities of about 693.94 million yuan, resulting in net assets of approximately 1.45 billion yuan [2] - The subsidiary reported a total revenue of approximately 443.45 million yuan, with a net loss of about 29.26 million yuan [2] - The company has no overdue guarantees or litigation related to guarantees as of the announcement date [4]

Group 1: Financing & Review - In May 2025, the Beijing Stock Exchange (BSE) issued 1 new stock, raising 168 million yuan; a total of 4 new stocks were issued from January to May 2025, raising a cumulative 1.702 billion yuan[5] - As of the end of May, there were 11 companies that had passed the review but not yet registered, with a proposed fundraising amount of 2.511 billion yuan; 1 company was registered but not yet issued, with a proposed fundraising of 200 million yuan[5] - The average proposed fundraising amount for companies under review is approximately 250 million yuan, with a total expected fundraising of 7.5 billion yuan for the year based on historical data[5] Group 2: Subscription & Issuance - In May 2025, 10 new companies were accepted for review, with 3 passing and 3 terminating; the acceptance rate shows a month-on-month increase[5] - The average first-day increase for new stocks in May was 441.68%, with a theoretical subscription return of 0.177%[3] - The cumulative return for new stock subscriptions from January to May 2025 was 0.50%, while the cumulative return for 2024 was 3.99%[3] Group 3: Market Trends & Predictions - The expected first-day increase for new stocks is set at 200%, with scenarios considering increases of 100%, 200%, and 300%[5] - The average online subscription amount in May was 7.99 million yuan, with a minimum investment threshold of 2.85 million yuan[34] - The online subscription rate is projected to be 0.056%, with variations based on different levels of frozen funds[5] Group 4: Investment Analysis & Risks - The high enthusiasm for new stock subscriptions is suppressing the subscription rate, which was only 0.03% in May due to the low fundraising amounts[5] - Risks include slower-than-expected issuance speed, lower-than-expected stock price increases, and potential macroeconomic downturns[5]

以下文章来源于中国企业家杂志 ，作者胡楠楠 中国企业家杂志 . 讲好企业家故事，弘扬企业家精神 每一次全球经济社会的低谷，都会酝酿产业浪潮和科技革命，因为人类在 寻找新的突破口。 文 ｜《中国企业家》记者 胡楠楠 编辑 ｜米娜 头图来源 ｜中企图库 12月13日~15日，由《中国企业家》杂志社主办的"2024（第二十二届）中国企业领袖年会"在 北京举行。国内著名经济学家、泽平宏观创始人任泽平出席本次年会，围绕"新周期"这个主 题，分享了他对2025年经济趋势的洞察。 以下为核心要点： 1.每一次全球经济社会的低谷，都会酝酿产业浪潮和科技革命，因为人类在 寻找新的突破口。 2.美联储降息打开了我们货币政策宽松的窗口。时隔14年，我们重新提出适 度宽松的货币政策。 3.明年国产替代、新质生产力可能会受到空前的重视。 4.第四次科技革命可能在7个领域爆发，比如新能源、人工智能、商业航 天、生物制造、基因技术、量子信息技术、可控核聚变。 5.新能源汽车已经进入淘汰赛，下半场是智能驾驶的时代，储能、氢能的时 代，这些在未来有大把的机会。 6.提振资本市场不仅有利于提振消费，还有利于中国的创新。 以下为任泽平现场演讲实录 ...